biologics
Takeda & PvP Biologics To Develop Drugs Against Celiac Disease
Takeda Pharmaceuticals and PvP Biologics have signed an agreement to develop therapeutics targeting celiac disease.
JHL Biotech Partners Sanofi For Biologics In China
Sanofi and JHL Biotech have formed a strategic alliance to develop and commercialize biological therapeutics for the Chinese market.
7 Must-Read Stories In October 2016
Sanofi Pasteur's dengue vaccine, low-protein diets and a ‘light-stopping’ experiment were popular in October.
Takeda Signs Cancer Therapeutics Collaboration With Crescendo Biologics
The collaboration will focus on discovery, development and commercialization of Humabodies®, a novel class of protein therapeutics.
AbbVie Opens API Manufacturing Facility In Singapore
The new manufacturing site in Singapore, AbbVie's first in Asia, will expand the company’s global operations for small molecule and biologics manufacturing.
WuXi AppTec To Build Biologics Solution Center
WuXi's Shanghai-based center, which will be operational by 2017, will provide integrated solutions for biologics discovery, development and clinical manufacturing.
Samsung BioLogics to Construct World’s Largest Biopharmaceutical Manufacturing Plant
Samsung BioLogics' US$724 million plant is set to begin operations in the fourth quarter of 2018.
Sanofi & Hanmi To Partner On New Diabetes Drugs
The Sanofi-Hanmi deal centers around longer-lasting biologics, which could reduce the frequency of treatment and dosage required for diabetic patients.
WuXi To Build World’s Largest Mammalian Cell Culture Facility
To be completed in January 2017, the cell culture facility will feature disposable bioreactors.
